Abbott Labs (NYSE:ABT) has never been shy about using M&A to build its business, and it was generally assumed that more deals would follow in the wake of the company's split with AbbVie (Nasdaq:ABBV).
While Monday is often the preferred day to announce deals, Abbott went
above and beyond this week with two acquisition announcements – both of
which could be highly promising down the line.
Please read the full article here:
http://www.investopedia.com/stock-analysis/071513/abbott-adds-two-promising-products-abt-vrx-mdt-bsx-cov.aspx
No comments:
Post a Comment